Dexmedetomidine as intramuscular premedication in outpatient cataract surgery. A placebo-controlled dose-ranging study. 1993

M Virkkilä, and T Ali-Melkkilä, and J Kanto, and J Turunen, and H Scheinin
Department of Anaesthesiology, Turku University Hospital, Finland.

Alpha 2 agonists have been shown to decrease intra-ocular pressure in ophthalmic surgery. We studied the effects of dexmedetomidine, a new alpha 2 agonist, on intra-ocular pressure, haemodynamic parameters, sedation, anxiolysis and dryness of mouth in 35 (ASA physical status 1-3) patients undergoing day-case cataract surgery under peri-ocular anaesthesia. Five different doses of dexmedetomidine (0.25, 0.5, 0.75, 1.0 and 1.5 micrograms.kg-1) were used in this double-blind, randomised and placebo-controlled study. The trial drug was administered into the deltoid muscle 60 min before surgery. The 1.0 micrograms.kg-1 dose of dexmedetomidine produced a 32% reduction of intra-ocular pressure (p = 0.002). This dose induced moderate sedation, but was not associated with significant haemodynamic changes. A significant decrease in heart rate and systolic blood pressure was seen only with the highest dose of dexmedetomidine. Our results suggest that dexmedetomidine 1.0 micrograms.kg-1 produces sedation and a reduction of intra-ocular pressure with minimal haemodynamic side effects when given intramuscularly as premedication before cataract surgery under regional anaesthesia.

UI MeSH Term Description Entries
D006993 Hypnotics and Sedatives Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. Hypnotic,Sedative,Sedative and Hypnotic,Sedatives,Hypnotic Effect,Hypnotic Effects,Hypnotics,Sedative Effect,Sedative Effects,Sedatives and Hypnotics,Effect, Hypnotic,Effect, Sedative,Effects, Hypnotic,Effects, Sedative,Hypnotic and Sedative
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D007429 Intraocular Pressure The pressure of the fluids in the eye. Ocular Tension,Intraocular Pressures,Ocular Tensions,Pressure, Intraocular,Pressures, Intraocular,Tension, Ocular,Tensions, Ocular
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D011229 Preanesthetic Medication Drugs administered before an anesthetic to decrease a patient's anxiety and control the effects of that anesthetic. Medication, Preanesthetic,Medications, Preanesthetic,Preanesthetic Medications
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002387 Cataract Extraction The removal of a cataractous CRYSTALLINE LENS from the eye. Enzymatic Zonulolysis,Phakectomy,Cataract Extractions,Enzymatic Zonulolyses,Extraction, Cataract,Extractions, Cataract,Phakectomies,Zonulolyses, Enzymatic,Zonulolysis, Enzymatic

Related Publications

M Virkkilä, and T Ali-Melkkilä, and J Kanto, and J Turunen, and H Scheinin
December 2014, Medical science monitor : international medical journal of experimental and clinical research,
M Virkkilä, and T Ali-Melkkilä, and J Kanto, and J Turunen, and H Scheinin
June 1993, Anesthesiology,
M Virkkilä, and T Ali-Melkkilä, and J Kanto, and J Turunen, and H Scheinin
April 1998, Journal of cardiovascular pharmacology and therapeutics,
M Virkkilä, and T Ali-Melkkilä, and J Kanto, and J Turunen, and H Scheinin
May 1991, Acta anaesthesiologica Scandinavica,
M Virkkilä, and T Ali-Melkkilä, and J Kanto, and J Turunen, and H Scheinin
January 1986, Acta anaesthesiologica Belgica,
M Virkkilä, and T Ali-Melkkilä, and J Kanto, and J Turunen, and H Scheinin
April 1977, Indian journal of ophthalmology,
M Virkkilä, and T Ali-Melkkilä, and J Kanto, and J Turunen, and H Scheinin
April 2020, BMC anesthesiology,
M Virkkilä, and T Ali-Melkkilä, and J Kanto, and J Turunen, and H Scheinin
December 2006, Journal of clinical anesthesia,
M Virkkilä, and T Ali-Melkkilä, and J Kanto, and J Turunen, and H Scheinin
January 1994, Journal of clinical anesthesia,
M Virkkilä, and T Ali-Melkkilä, and J Kanto, and J Turunen, and H Scheinin
October 1983, Anaesthesia,
Copied contents to your clipboard!